References for Joslin’s Clinical Guideline for Adults with Diabetes

02/27/08
SUBJECT AUTHORS TITLE JOURNAL
A1C 1 The absence of a glycemic threshold
for the development of long term
American Diabetes
complications: the perspective of the Diabetes. 1996 Oct; 45(10): 1289-98
Association
Diabetes Control and Complications
Trial
2 Immediate feedback of HbA1c levels
Cagliero E, Levina EV, Nathan improves glycemic control in type 1
Diabetes Care. 1999 Nov; 22(11): 1785-9
DM and insulin-treated type 2 diabetic
patients
3 Clinical use of hemoglobin A1c to
Delamater A Clinical Diabetes. 2006, Vol. 24, (1)
improve diabetes management
4 Effect of immediate hemoglobin A1c
Ferenczi A, Reddy K, Lorber
results on treatment decisions in Endocr Pract. 2001 Mar-April; 7(2): 85-8
DL
office practice
5 Self-monitoring of blood glucose
Karter AJ, Ackerson LM,
levels and glycemic control: The
Darbinian JA, D'Agostino RB Am J Med. 2001 Jul; 111(1): 1-9
Northern California Kaiser
Jr, Ferrara A, Liu J, Selby JV
Permanente Diabetes Registry
6
Haemoglobin A1c-a marker for
complications of type 2 diabetes: the
Manley S Clin Chem Lab Med. 2003 Sep; 41(9): 1182-90
experience from the UK Prospective
Diabetes Study (UKPDS)

7 Martin DD, Shephard MD,

Point of care testing: HbA1c and
Freeman H, Bulsara MK,
blood glucose in a remote Aboriginal Med J Aust. 2005 May 16; 182(10): 524-7
Jones TW, Davis EA, Maguire
Australian community
GP
8 Miller CD, Barnes CS, Phillips
Rapid A1c availability improves
LS, Ziemer DC, Gallina DL,
clinical decision making in an urban Diabetes Care. 2003 26:1158-1163
Cook CB, Maryman SD, El-
primary care clinic
Kebbi IM
9
Diabetes in urban African
Thaler LM, Ziemer DC, Gallina
Americans. XVII. Availability of rapid
DL, Cook CB, Dunbar VG, et Diabetes Care. 1999 Sep; 22(9): 1415-21
HbA1c measurements enhances
al
clinical decision making

1
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 10 The relationship of glycemic
exposure (HbA1c) to the risk of
American Diabetes
development and progression of Diabetes. 1995 Aug; 44(8): 968-83
Association
retinopathy in the diabetes control
and complications trial
11 Intensive insulin regimens: evidence Int J Obes Relat Metab Disord. 2004 Sep; 28
Bretzel RG
for benefit Suppl 2:S8-13
12 Issues surrounding tight glycemic
Cerveny JD, Leder RD, Weart
control in people with type 2 Ann Pharmacother. 1998 Sep; 32(9): 896-905
CW
diabetes mellitus
13
The effect of intensive treatment of
diabetes on the development and
progression of long-term
DCCT complications in the insulin- N Engl J Med. 1993 Sep 30; 329(14): 977-86
dependent diabetes mellitus. The
Diabetes Control and Complications
Trial Research Group

14 Relation of glycemic control to

Klein R, Klein BE diabetic complications and health Diabetes Care. 1998 Dec; 21 Suppl 3:C39-43
outcomes
15
Methods for quantifying self-
Kovatchev BP, Cox DJ, monitoring blood glucose profiles
Gonder-Frederick L, Clarke exemplified by an examination of Diabetes Technol Ther. 2002; 4(3): 295-303
WL blood glucose patterns in patients
with type 1 and type 2 diabetes

BLOOD PRESSURE 1 Association of systolic blood

Adler AI, Stratton IM, Neil HA,
pressure with macrovascular and
Yudkin JS, Matthews DR, Cull
microvascular complications of type BMJ. 2000 Aug 12; 321(7258): 412-9
CA, Wright AD, Turner RC,
2 diabetes (UKPDS 36): Prospective
Holman RR
observational study
2
The Seventh Report of the Joint
National Committee on Prevention,
Chobanian AV et al JAMA. 2003 May; 289(19): 2560-2572
Detection, Evaluation, and
Treatment of High Blood Pressure

3 Effects of intensive blood pressure

Hansson L, Zanchetti A,
Carruthers SG, Dahlof B,
Elmfeldt D, Julius S, Menard J,
et al
lowering and low dose aspirin in
patients with hypertension: Principal
Lancet. 1998 Jun 13; 351(9118): 1755-62
results of the Hypertension Optimal
Treatment (HOT) randomised trial.
HOT study group

2
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 4
Age-specific relevance of usual
Lewington S, Clarke R,
blood pressure to vascular mortality:
Qizilbash N, Peto R, Collins R;
A meta-analysis of individual data Lancet. 2002 Dec 14; 360(9349): 1903-13
Prospective Studies
for one million adults in 61
Collaboration
prospective studies

5
Ramsay LE, Williams B,
Johnston GD, MacGregor GA,
Poston L, Potter JF, Poulter
NR, Russel G
Guidelines for management of
hypertension: Report of the third
J Hum Hypert. 1999; 13:569-92
working party of the British
Hypertension Society

6 Tight blood pressure control and risk

of macrovascular and microvascular
UKPDS complications in type 2 diabetes: BMJ. 1998 Sep 12; 317(7160): 703-13
UKPDS 38. UK Prospective
Diabetes Study Group
7
Treatment of hypertension in type 2
diabetes mellitus: Blood pressure
Vijan S, Hayward RA Ann Intern Med. 2003 Apr 1; 138(7): 593-602
goals, choice of agents, and setting
priorities in diabetes care

CARDIOVASCULAR 1
HEALTH
American Diabetes Peripheral arterial disease in people
Diabetes Care. 2003 26(12): 3333-3341
Association with diabetes

2 Collaborative overview of
randomised trials of antiplatelet
therapy--I: Prevention of death,
Antiplatelet Trialists'
myocardial infarction, and stroke by BMJ. 1994 Jan 8; 308(6921): 81-106
Collaboration
prolonged antiplatelet therapy in
various categories of patients.
Antiplatelet Trialists' Collaboration
3 Effects of exercise on glycemic
Boule NG, Haddad E, Kenny control and body mass in type 2
JAMA 2001 Sep; 286(10): 1218-27
GP, Wells GA, Sigal RJ diabetes mellitus: a meta-analysis of
controlled clinical trials
4

Meta-analysis of the effect of

Boule NG, Kenny GP, Haddad structured exercise training on
Diabeteologia 2003; 46:1071-1081
E, Wells GA, Sigal RJ cardiorespiratory fitness in type 2
diabetes mellitus

3
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 5
Bredie SJ, Wollersheim H, Low-dose aspirin for primary
Semin Vasc Med. 2003 May; 3(2): 177-84
Verheugt FW, Thien T prevention of cardiovascular disease

6 Catella-Lawson F, Muredach
RP, Kapoor SC, Cucchiara AJ,
DeMarco S, Tournier B, Vyas
SN, Fitzgerald GA
7 Primary prevention of cardiovascular
Colhoun HM, Betteridge DJ,
Durrington PN, Hitman GA, et
al
8
Colwell JA
Cyclooxygenase inhibitors and the
N Engl J Med. 2001 Dec 20; 345(25): 1809-1817
antiplatelet effects of aspirin
disease with atorvastatin in type 2
diabetes in the collaborative
Lancet. 2004. Aug 21; 364:685-696
atorvastatin diabetes study
(CARDS): Multicentre randomised
placebo-controlled trial
Antiplatelet agents for the prevention
of cardiovascular disease in Am J Cardiovasc Drugs. 2004; 4(2): 87-106
diabetes mellitus

9
Effect of intensive therapy on
residual beta cell function in patients
with type 1 diabetes in the diabetes
DCCT control and complications trial. A Ann Intern Med. 1998 Apr 1; 128(7): 517-23
randomized, controlled trial. The
Diabetes Control and Complications
Trial Research Group
10 Aspirin effects on mortality and
morbidity in patients with diabetes
ETDRS Investigators mellitus. Early Treatment Diabetic JAMA. 1992 Sep 9; 268(10): 1292-300
Retinopathy Study report 14.
ETDRS Investigators
11

Aspirin for the primary prevention of

Hayden M, Pignone M, Phillips cardiovascular events: A summary
Ann Intern Med. 2002 Jan 15;136(2):161-72
C, Mulrow C of the evidence for the U.S.
Preventive Task Force

12

Aspirin in cardiovascular disorders.

Kong DF Am J Cardiovasc Drugs. 2004;4(3):151-8
What is the optimum dose?

4
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 13 Lindholm LH, Ibsen H, Dahlof
B, Devereux RB, Beevers G,
Cardiovascular morbidity and
de Faire U, Fyhrquist F, Julius
mortality in patients with diabetes in
S, Kjeldsen SE, Kristiansson
the Losartan Intervention for
K, Lederballe-Pedersen O, Lancet. 2002 Mar 23;359(9311):1004-10
Endpoint reduction in hypertension
Nieminen MS, Omvik P, Oparil
study (LIFE): A randomised trial
S, Wedel H, Aurup P, Edelman
against atenolol
J, Snapinn S; LIFE Study
Group
14 Meigs JB, Larson MG,
Coronary artery calcification in type
D'Agostino RB, Levy D,
2 diabetes and insulin resistance: Diabetes Care. 2002 Aug;25(8):1313-9.
Clouse ME, Nathan DM,
the Framingham offspring study
Wilson PW, O'Donnell CJ
15

Nguyen KX, Marinac JS, Sun Aspirin for primary prevention in

Fam Med. 2005 Feb; 37(2):112-7
C patients with diabetes mellitus

16
Prevention of cardiovascular
Nobles-James C, James EA,
complications of diabetes mellitus by Cardiovasc Drug Rev. 2004 Fall; 22(3):215-26
Sowers JA
aspirin

17 Aspirin dose for prevention of

Nowak SN, Jaber LA Ann Pharmacother. 2003 Jan;37(1):116-21
cardiovascular disease in diabetics
18 The effect of long term intensified
Reichard P, Nilsson BY, insulin treatment on the
N Engl J Med. 1993 Jul 29;329(5):304-9
Rosenqvist U development of microvascular
complications of diabetes mellitus
19 Primary prevention of cardiovascular
Sacco M, Pellegrini F,
events with low-dose aspirin and
Roncaglioni MC, Avanzini F,
vitamin E in type 2 diabetic patients: Diabetes Care. 2003 Dec;26(12):3264-72
Tognoni G, Nicolucci A; PPP
Results of the Primary Prevention
Collaborative Group
Project (PPP) trial
20 Diabetes, other risk factors, and 12-
Stamler J, Vaccaro O, Neaton yr cardiovascular mortality for men
Diabetes Care. 1993 Feb; 16(2):434-44
JD, Wentworth D screened in the multiple risk factor
intervention trial

5
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 21
Final report on the aspirin
Steering Committee of the component of the ongoing
Physicians' Health Study Physicians' Health Study. Steering N Engl J Med. 1989 Jul 20;321(3):129-35
Research Group Committee of the Physicians' Health
Study Research Group

22 Association of glycemia with

Stratton IM, Adler AI, Neil HA, macrovascular and microvascular
Matthews DR, Manley SE, Cull complications of type 2 diabetes BMJ. 2000 Aug 12;321(7258):405-12
CA, et al (UKPDS 35): Prospective
observational study
23
Effects of an angiotensin-converting
The Heart Outcomes
enzyme inhibitor, ramipril, on
Prevention Evaluation Study N Engl J Med. 2000 Jan 20;342(3):145-153
cardiovascular events in high risk
Investigators
patients

24 Tuomilehto J, Rastenyte D,
Birkenhager WH, Thijs L,
Antikainen R, Bulpitt CJ,
Effects of calcium-channel blockade
Fletcher AE, Forette F,
in older patients with diabetes and N Engl J Med. 1999;340(9):677-84
Goldhaber A, Palatini P, Sarti
systolic hypertension
C, Fagard R; Systolic
Hypertension in Europe Trial
Investigators
25
Aspirin for the primary prevention of
US Preventive Task Force cardiovascular events: Ann Intern Med. 2002 Jan 15;136(2):157-160
Recommendation and rationale

26

Accord Tele-briefing prepared www.nhlbi.nih.gov/health/prof/heart/other/ac

Nabel E
T

remarks 2/6/2008 cord/nabel_remarks.htm - 38k - T

DENTAL CARE 1

American Academy of
Diabetes and periodontol disease J Periodontol 1996 Feb;166-76
Periodontology

2 Periodontal disease related to

diabetic status. A pilot study of the
Karjalainen K TT J Clin Periodont 1997; 24: 505-510
response to periodontal therapy in
type 1 diabetes

6
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 3 Type 1 diabetes mellitus and oral
Simpson TC, Needleman IG,
health: Assessment of periodontal Cochrane Dat Syst Rev. 2004;2(CD004714)
Wild SH, Moles DR, Mills EJ
disease
4 Routine dental visits are associated
Tervonen T, Karjalainen K with tooth retention in Brazilian J Clin Periodontol. 1997 Jul;24(7):505-10
adults: The Pro-Saude study
5 Moore PA, Weyant RJ, Periodontal disease related to
Mongelluzo MB, Myers DE, diabetic status. A pilot study of the
J Periodontol. 1999 Apr;70(4):409-17
Rossie K, Guggenheimer J, response to periodontal therapy in
Block HM, Huber H, Orchard T type 1 diabetes
DIABETES SELF- 1 Cox DJ, Gonder-Frederick LA, Effects and correlates of blood
MANAGEMENT Lee JH, Julian DM, Carter WR, glucose awareness training among Diabets Care. 1989 May;12(5):313-8
EDUCATION Clarke WL patients with IDDM
2 Intensive versus standard blood
Cox DJ, Gonder-Frederick L,
glucose awareness training (BGAT)
Julian D, Cryer P, Lee JH, Psychosom Med. 1991 Jul-Aug;53(4):453-62
with insulin-dependent diabetes:
Richards FE, Clarke W
Mechanisms and ancillary effects
3
Cox DJ, Gonder-Frederick L,
Blood glucose awareness training
Polonsky W, Schlundt D, Diabetes Care. 2001 Apr;24(4):637-42
(BGAT-2): Long-term benefits
Kovatchev B, Clarke W

4 Kinsley BT, Weinger K, Bajaj Blood glucose awareness training

M, Levy CJ, Simonson DC, and epinephrine responses to
Diabetes Care. 1999 Jul;22(7):1022-8
Quigley M, Cox DJ, Jacobsen hypoglycemia during intensive
AM treatment in type 1 diabetes
5 The 1999 Scope of Practice for
Diabetes Educators and the
American Association of
Standards of Practice for Diabetes Diabetes Educ. 2000 Jan-Feb;26(1):25-31
Diabetes Educators
Educators. American Association of
Diabetes Educators
6

American Association of Individualization of diabetes self

Diabetes Educ. 2002 Sep-Oct;28(5):741-5, 749
Diabetes Educators management education

7 Standards for outcomes

American Association of
Diabetes Educators
8 American Diabetes
Association Task Force for
Writing Nutrition Principles and
Recommendations for the
Management of Diabetes and
Related Complications
Diabetes Educ. 2003 Sep-Oct;29(5):804, 808-
measurement of diabetes self
10,813-6
management education
American Diabetes Association
position statement: Evidence-based
nutrition principles and
J Am Diet Assoc. 2002 Jan;102(1):109-18
recommendations for the treatment
and prevention of diabetes and
related complications

7
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 9
Diabetes self-management training
Banister NA, Jastrow ST,
program in a community clinic
Hodges V, Loop R, Gillham J Am Diet Assoc. 2004 May;104(5):807-10
improves patient outcomes at
MB
modest community

10 Blood glucose awareness training in

Broers S, van Vliet KP, le
Cessie S, Spinhoven P, van
der Ven NC, Radder JK
11 Broers S, van Vliet KP, le
Cessie S, Spinhoven P, van
der Ven NC, Radder JK
12
Dutch type 1 diabetes patients:
Diabet Med. 2002 Feb;19(2):157-61
Short-term evaluation of individual
and group training
Blood glucose awareness training in
Dutch type 1 diabetes patients: One Neth J Med. 2005 May;63(5):16409
year follow up

Group based training for self-

Deakin T, McShane CE, Cade Cochrane Database Syst Rev. 2005 Apr
management strategies in people
JE, Williams RD 18;(2):CD003417
with type 2 diabetes mellitus

13 Long-term effects of self-

Goudswaard AN, Stolk RP,
Zuithoff NP, de Valk HW,
Rutten GE
14
Mensing C, Lasichak A,
Boucher J, Lamb B, et al
management education for patients
with Type 2 diabetes taking maximal Diabet Med. 2004 May;21(5):491-6
oral hypoglycaemic therapy: a
randomized trial in primary care
National Standards for Diabetes
Diabetes Care. 2006 Jan;29(Suppl 1):S78-S85
Self-Management Education

15 Mulcahy K, Maryniuk M,
Diabetes self management Diabetes Educ. 2003 Sep-Oct;29(5):768-70, 773-
Peeple M, Peyrot M, Tomky D,
education core outcomes measures 84, 787-8
Weaver T, Yarborough P
16 Effectiveness of self-management
Norris SL, Engelgau MM, training in type 2 diabetes: a
Diabetes Care. 2001 Mar;24(3):561-87
Narayan KM systemic review of randomized
controlled trials
17
Long-term effectiveness of lifestyle
and behavioral weight loss The American Journal of Medicine. 2004 Nov;
Norris SL et al
interventions in adults with type 2 117:762-74
diabetes: A meta-analysis

18 Self-management education for

Norris SL, Lau J, Smith SJ, adults with type 2 diabetes: A meta-
Diabetes Care. 2002 Jul;25(7):1159-71
Schmid CH, Engelgau MM analysis of the effect on glycemic
control

8
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 19 Integrating medical management
Polonsky WH, Earles J, Smith
with diabetes self-management
S, Pease DJ, Macmillan M,
training: A randomized control trial of Diabetes Care. 2003 Nov;26(11):3048-53
Christensen R, Taylor T,
the Diabetes Outpatient Intensive
Dickert J, Jackson RA
Treatment program
20 The impact of formal diabetes
Strine TW, Okoro CA,
education on the preventive health Prev Med. 2005 Jul;41(1):79-84. Epub 2004 Nov
Chapman DP, Beckles GL,
practices and behaviors of persons 19
Balluz L, Mokdad AH
with type 2 diabetes
21 Self-management education
programs in chronic disease: A
Warsi A, Wang PS, LaValley
systematic review and Arch Intern Med. 2004 Aug 9-23;164(15):1641-9
MP, Avorn J, Solomon DH
methodological critique of the
literature
22
Exercise training in treatment of
Schwartz RS Diabetes Care. 1990;13(Suppl 2):77-85
diabetes mellitus in elderly patients

23 Intensive blood-glucose control with

sulphonylureas or insulin compared
UKPDS with conventional treatment and risk Lancet. 1998 Sep 12;352(9131):837-53
of complications in patients with type
2 diabetes (UKPDS 33)
24 Effect of intensive blood glucose
control with metformin on
complications in overweight patients
UKPDS Lancet. 1998 Sep 12;352(9131):854-65
with type 2 diabetes (UKPDS 34).
UK Prospective Diabetes Study
(UKPDS) Group
25 Short term effects of cognitive
Van der Ven NC, Hogenelst
behavioural group training (CBGT)
MH, Tromp-Wever AM, Twisk
in adult type 1 diabetes patients in Diabetes Med. 2005 Nov;22(11): 1619-23
JW, van der Ploeg HM, Heine
prolonged poor glycaemic control. A
RJ, Snoek FJ
randomized controlled trial
26 Meta-analysis of the effects of
intensive glycemic control on late Online J Curr Clin Trials. 1993 May 21;Doc No
Wang PH, Lau J, Chalmers TC
complications of type I diabetes 60:[5023 words; 37 paragraphs]
mellitus
27
Controlling blood glucose levels in
patients with type 2 diabetes
Woolf SH, Davidson MB, mellitus. An evidence based policy
J Fam Pract. 2000 May;49(5):453-60
Greenfield S, Bell HS, et al statement by the American
Academy of Family Physicians and
American Diabetes Association

9
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 28

Daly A, Franz MJ, Holzmeister

New diabetes nutrition resources J Am Diet Assoc. 2003;103(7):832-4
LA, et al

29
Expanded role of the dietitian in the
DCCT diabetes control and complications J Am Diet Assoc. 1993;93(7):758-767
trial: implications for clinical practice

30 The role of diet behaviors in

achieving improved glycemic control
Delahanty LM, Halford BN in intensively treated patients in the Diabetes Care. 1993;16(11):1453-58
diabetes control and complications
trial
31
Evidence-based nutrition principles
Franz MJ, Bantle JP, Beebe and recommendations for the
Diabetes Care. 2002 Jan(25)1:148-98
CA et al treatment and prevention of diabetes
and related complications

32 Evidence-based nutrition principles

Franz MJ, Bantle JP, Beebe and recommendations for the
Diabetes Care. 2003 Jan;26 Suppl1:S51-61
CA et al treatment and prevention of diabetes
and related complications
33
Franz MJ, Bantle JP, Beebe Nutrition principles and
Diabetes Care. 2004 Jan;27 Suppl 1:S36-46
CA et al recommendations in diabetes

34
Cost-effectiveness of medical
Franz MJ, Splett PL, Monk A, nutrition therapy provided by
J Am Diet Assoc. 1995;95(9):1018-1024
et al dieticians for persons with non-
insulin dependent diabetes mellitus

35

Medical nutrition therapy for

Franz MJ Diabetes Spectrum. 2006 19:32-38
hypertension and albuminuria

36

Evidence based medical nutrition

Franz MJ. Nutr Clin Pract. 2004 Apr;19(2):137-44
therapy for diabetes

10
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 37 Interventions to promote diabetes
Brown SA self-management: state of the Diabetes Educ. 1999 Nov-Dec;25(6 Suppl):52-61
science
38
Evidence-based nutrition principles
American Diabetes and recommendations for the
Diabetes Care. 2002 Jan;25(1):202-212
Association treatment and prevention of diabetes
and related complications

39 Evidence-based nutrition principles

American Diabetes
and recommendations for the Nutr Clin Care. 2003 Oct-Dec;6(3):115-9
Association
treatment and prevention of diabetes
40 Nutrition practice guideline care
Geil P, Leontos C Diabetes Spectrum. 2004;17(2):83-86
improves diabetes outcomes
41 Medical nutrition therapy in non-
Johnson EQ, Valera S insulin dependent diabetes mellitus J Am Diet Assoc. 1995;95(6):700-1
improves clinical outcome
42
The evidence for the effectiveness
Pastors JG, Warshaw h, Daly Diabetes Care, Volume 25, Number 3, March
of medical nutrition therapy in
A, Franz M, Kulkarni k 2002
diabetes management

43 New evidence-based diabetes

nutrition recommendations:
Pearce LC Home Health Nurse. 2003 Apr;21(4):249-57
Correcting myths and updating
practice
44 The effect of dietary protein
Pedrini MT, Levey AS, Lau J, restriction on the progression of
Ann Intern Med. 1996 Apr 1;124(7):627-32
Chalmers TC, Wang PH diabetic and nondiabetic renal
diseases: A meta-analysis
45 Dietitian intervention improves lipid
values and saves medication costs
Sikand G, Kashyap ML, Wong
in men with combined J Am Diet Assoc.2000;100(2):218-224
ND, et al
hyperlipidemia and a history of
niacin noncompliance
EYES 1
American Academy of American Academy of Ophthalmology. 2003
Diabetic retinopathy
Ophthalmology Retina Panel Preferred Practice Pattern

2
Diabetic retinopathy and diabetic
Ciulla T, Amador A, Zinman B Diabetes Care. Vol 26, No. 9, Sept 2003
macular edema

3
Early worsening of diabetic
DCCT retinopathy in the Diabetes Control Arch Ophthalmol. 1998 Jul;116(7):874-86
and Complications Trial

11
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 4 Retinopathy and nephropathy in
patients with type 1 diabetes four
years after a trial intensive therapy.
DCCT The Diabetes Control and N Engl J Med. 2000 Feb 10;342(6):381-9
Complications Trial/Epidemiology of
Diabetes Interventions and
Complications Research Group
5 Early worsening of diabetic
Arch. Of Ophthalmology. Vol 116(7): July 1998;
DCCT retinopathy in the Diabetes Control
874-886
and Complications Trial
6 Progression of retinopathy with
intensive versus conventional
DCCT Ophthalmology 1995;102:647-661
treatment in the Diabetes Control
and Complications Trial
7 Early Treatment Diabetic
Photocoagulation for diabetic Arch. Ophthalmology vol. 103, Dec 1985; 1796-
Retinopathy Study Research
macular edema 1806
Group
8
Fong D, Cavallerano J, Aiello
Diabetic retinopathy Diabetes Care, Vol 26. No. 1; Jan 2003
L, Ferris F, King G, et al

Fong D, Cavallerano J, Aiello

Retinopathy in diabetes Diabetes Care. Vol 27, Suppl. 1, January 2004
L, Ferris F, King G, et al

10
Fong D, Cavallerano J, Aiello Fundus photographic risk factors for
Diabetes Care. Vol.27, Suppl 1, January 2004
L, Ferris F, King G, et al progression of diabetic retinopathy

11
Fong D, Ferris F, Klein R,
Diabetic retinopathy Diabetes Care, Vol 27; No. 10; October 2004
Aiello L

12 Fransen SR, Leonard-Martin

TC, Feuer WJ, Hildebrand PL; Clinical evaluation of patients with
Ophthalmology 2002;109:595-601
The Inoveon Health Research diabetic retinopathy
Group
13 Longitudinal rates of annual eye
Lee P, Feldman Z, Ostermann
examinations of persons with Ophthalmology 2003;110:1952-1959
J, Brown D, Sloan F
diabetes and chronic eye diseases
14 How frequently should patients with
Murphy C, Newton W type 2 diabetes mellitus be screened J Fam Pract. Vol 49(5). May 2000.395-396
for retinopathy?
15 Cost-utility analysis of screening
Sandeep V, Hofer TP,
intervals for diabetic retinopathy in JAMA. 2000 Feb; 16(889-896)
Hayward R
patients with type 2 diabetes Mellitus

12
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 16 Cost-utility analysis of screening
intervals for diabetic retinopathy in
Vijan S, Hofer T, Hayward R. JAMA. Vol 283(7). Feb 16, 2000.889-896
patients With type 2 diabetes
mellitus
17 Prevalence of diabetic eye disease
Younis N, Broadbent D, Vora in patients entering a systemic
Diabetic Medicine, 19, 1014-1021. 2002
J, Harding S primary care based eye screening
programme
18
Incidence of sight-threatening
Younis N, Broadbent D, Vora
retinopathy in type 1 diabetes in a Diabetic Medicine, 20, 758-765, 2003
J, Harding S
systemic screening programme

19 Incidence of sight-threatening
Younis N, Broadbent D, Vora retinopathy in patients with type 2
The Lancet. Vol 361, Jan 18, 2003
J, Harding S diabetes in the Liverpool Diabetic
Eye Study: A cohort study
20
American Optometric
Care of the patient with diabetes
Association Consensus Panel American Optometric Association
mellitus
on Diabetes

21 The Wisconsin Epidemiologic Study

Klein R, Klein BEK, Moss SE,
Davis ME, DeMets DL
22
Klein R, Klein BEK, Moss SE,
Cruickshanks KJ
23 Palmberg P, Smith M,
Waltman S, Krupin T, Singer
P, Burgess D, Wendtlant T,
Achtemberg J, Cryer P,
Santiago J, White N, Kilo C,
Daughaday W
24 Frank R, Hoffman W, Podgor
M, Joondeph H, Lewis R,
Margherio R, Nachazel D,
Weiss H, Christopherson K,
Cronin M
25
Kohner E, Aldington S,
Stratton I, Manley S, Holman
R, Matthews D, Turner R
of Diabetic Retinopathy II.
Prevalence and risk of diabetic Arch Ophtalmol 1984;102:520-526
retinopathy when age at diagnosis is
less than 30 years
The Wisconsin Epidemiologic Study
of Diabetic Retinopathy: XVII. The
14 year incidence and progression
Ophthalmology 1998;105:1801-1815
of diabetic retinopathy and
associated risk factors in type 1
diabetes
The natural history of retinopathy in
insulin-dependent juvenile-onset Ophthalmology 1980;87:1-9
diabetes
Retinopathy in juvenile-onset
Ophthalmology 1980;87:1-9
diabetes of short duration
United Kingdom Prospective
Diabetes Study: Diabetic retinopathy
at diagnosis of non-insulin Arch Ophthalmol 1998;116:297-303
dependent diabetes mellitus and
associated risk factors

13
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 26
Saxer-Siegel R, Hod M, Fink-
Cohen S, Kramer M, Diabetic retinopathy during
Ophthalmology 1996;103:1815-1819
Weinberger D, Schindel B, pregnancy
Yassur Y

27
Chew E, Mills J, Metzger B, National Institute of Child Health and
Remalley N, Joanovic- Human Development Diabetes in
Peterson L, Knopp R, Conley Early Pregnancy Study. Metabolic Diabetes Care 1995;18:631-7
M, Rand L, Simpson J, control and progression pf
Holmes L, Aarons J retinopathy

28

Effect of pregnancy on progression

Klein BEK, Moss S, Klein R. Diabetes Care 1990;13:34-40
of diabetic retinopathy

29
Early Treatment Diabetic
Early Treatment Diabetic
Retinopathy Study Report Number
Retinopathy Study Research Ophthalmology 1991;98:766-785
9: Early photocoagulation for
Group
diabetic retinopathy

30
Early Treatment Diabetic
Retinopathy Study Report Number
Early Treatment Diabetic
10: Grading diabetic retinopathy
Retinopathy Study Research Ophthalmology 1991;98:786-806
from stereoscopic color fundus
Group
photographs- An extension of the
modified Airlie House Classification
31 Early Treatment Diabetic
Early Treatment Diabetic Retinopathy Study Report Number
Retinopathy Study research 12: Fundus photographic risk factors Ophthalmology 1991;98:823-33
Group for progression of diabetic
retinopathy
FEET 1
Disease management for the
diabetic foot: Effectiveness of a
Lavery LA, Wunderlich RP, Diabetes Res Clin Pract. 2005 Oct; 0(1):31-7.
diabetic foot prevention program to
Tredwell JL Epub 2005 Mar 31
reduce amputations and
hospitalizations

2 American Diabetes Consensus development conference

Diabetes Care. 1999 Aug; 22(8):1354-1360
Association on diabetic foot wound care

14
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 3
American Diabetes Consensus development conference
Diabetes Care. 1999 Aug; 22(8):1354-1360
Association on diabetic foot wound care

American Diabetes
Preventive foot care in diabetes Diabetes Care. 2004 27(Suppl 1):S63-S64
Association

Lowering the risk of neuropathy, foot

Boulton AJ Diabet Med. 1998;15 Suppl 4:S57-9
ulcers and amputations

6 The Diabetic Foot 2001. A summary

of the proceedings of the American
Frykberg RG, Armstrong DG J Am Podiatr Med Assoc. 2002 Jan;92(1):2-6
Diabetes Association's 61st
Sceintific Symposium
7
Risk factors associated with healing
Marston WA chronic diabetic foot ulcers: The Ostomy Wound Manage. 2006 Mar;52(3):26-39
importance of hyperglycemia

8
Mayfield, Janisse D, Reiber Preventive foot care in people with
Diabetes Care. 1998 21(12):2161-2177
GE, Pogach LM, Sanders LJ diabetes

9 Which diabetic patients should

McGill M, Molyneaux L, Yue
receive podiatry care? An objective Intern Med J. 2005 Aug;35(8):451-6
DK
analysis
10 Screening techniques to identify
Pham H, Armstrong DG,
people at high risk for diabetic foot
Harvey C, Harkless LB, Giurini Diabetes Care. 2000 May;23(5):606-11
ulceration: A prospective multicenter
JM, Veves A
trial
11 Prevention of diabetes-related foot
Ragnarson Tennvall G, ulcers and amputations: A cost-utility
Diabetologia. 2001 Nov;44(11):2077-87
Apelqvist J analysis based on Markov model
simulations
12
Singh N, Armstrong DG, Preventing foot ulcers in patients
JAMA. 2005 Jan 12;293(2):217-28
Lipsky BA with diabetes

15
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 13
Ulbrecht JS, Cavanagh PR, Foot problems in diabetes: An
Clin Infect Dis. 2004 Aug 1;39 Suppl 2:S73-82
Caputo GM overview

14 Valk GD, Kriegsman DM, Patient education for preventing Cochrane Database Syst Rev. 2005 Jan
Assendelft WJ diabetic foot ulceration 25;(1):CD001488
GENERAL 1
American Diabetes Standards of medical care in
Diabetes Care. 2006 Jan;29 Suppl 1:S4-S42
Association diabetes-2006

GLUCOSE 1 The role of self-monitoring of blood

MONITORING Bergenstal RM, Gavin JR 3rd;
Global Consensus Conference
on Glucose Monitoring Panel
2
Blonde L, Karter AJ
glucose in the care of people with
Am J Med. 2005 Sep;118(suppl 9A):1S-6S
diabetes: A report of a global
consensus conference
Current evidence regarding the
value of self-monitored blood Am J Med. 2005 Sep;118(suppl 9A):20S-26S
glucose testing

3 The impact of blood glucose self-

Franciosi M, Pelligrini F, De
Berardis G, Belfiglio M,
Cavaliere D, Di Nardo B,
Greenfield S, Kaplan SH, et al
4 Franciosi M, Pelligrini F, De
Berardis G, Belfiglio M, Di
Nardo B, Greenfield S, Kaplan
SH, Rossi MC, Sacco M, et al
5 Self-monitoring of glucose by people
Gallichan M
6 Glycated hemoglobin assessment in
Kennedy L, Herman WH;
GOAL A1c Study Team
7 Cox DJ, Gonder Frederick L,
Julian DM, Clarke W
8 Frequency of blood glucose
Evans JM, Newton RW, Ruta
DA, MacDonald TM,
Stevenson RJ, Morris AD
9
Saudek CD, Rastogi R
monitoring on metabolic control and
quality of life in type 2 diabetic Diabetes Care. 2001 Nov;24(11):1870-7
patients: An urgent need for better
educational strategies
Self-monitoring of blood glucose in
non-insulin treated diabetic patients:
Diabet Med. 2005 Jul;22(7):900-6
A longitudinal evaluation of its
impact on metabolic control
with diabetes: Evidence based BMJ. 1997 Mar 29;314(7085):964-7
practice
clinical practice: Comparison of the
new A1cNow point-of care device Diabetes Technol Ther. 2005 Dec;7(6):907-12
with central laboratory testing
(GOAL A1C Study)
Long-term follow-up evaluation of
Diabetes Care. 1994 Jan; 17(1):1-5
blood glucose awareness training
monitoring in relation to glycemic
BMJ. 1999 Jul 10;319(7202):83-86
control: Observational study with
diabetes database
Assessment of glycemia in diabetes
mellitus -- self-monitoring of blood J Assoc Physicians India. 2004 Oct; 52:809-15
glucose

16
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 10 Optimal glycemic control in type 2
Abrahamson MJ diabetes mellitus: Fasting and Arch Intern Med. 2004 Mar 8;164(5):486-91
postprandial glucose in context
11
Effect of long term monitoring of
Larsen ML, Horder M,
glycosylated hemoglobin levels in N Engl J Med. 1990. Oct 11; 323(15): 1021-1025
Mogensen EF
insulin-dependent diabetes mellitus

12

Monitoring glycemic control: The

LeRoith D, Smith DO Clin Ther. 2005 Oct;27(10):1489-99
cornerstone of diabetes care

13 Reduction in self-monitoring of blood

Meier JL, Swislocki AL, Lopez
glucose in persons with type 2
JR, Noth RH, Bartlebaugh P, Am J Manag Care. 2002 Jun;8(6):557-65
diabetes results in cost savings and
Siegel D
no change in glycemic control
14 The relationship between self-
monitoring of blood glucose control
J Diabetes Complications. 2003 May-
Ozmen B, Boyvada S and glycosylated hemoglobin in
Jun;17(3):128-34
patients with type 2 diabetes and
without diabetic retinopathy
15 Monitoring glycemic control: The
Renard E importance of self-monitoring of Am J Med. 2005 Sep;118(Suppl 9A):12S-19S
blood glucose
16
Patient adherence improves The Diabetes Educator 2005 March/April
Rhee MK et al
glycemic control 31(2):240-250

17 Blood glucose self monitoring in

Schiel R, Muller UA, Rauchfub
J, Sprott H, Muller R
18
Valeri C, Pozzili P, Leslie D
insulin treated type 2 diabetes
Diabetes Metab. 1999 Sep;25(4):334-40
mellitus: A cross-sectional study with
an intervention group
Diabetes Metab Res Rev. 2004 Nov-Dec;20
Glucose control in diabetes
Suppl 2:S1-8

19
Strategies for improving glycemic
Davidson J control: Effective use of glucose Am J Med. 2005;118(9A):27S-32S
monitoring

20 The importance of tight glycemic

Gerich JE Am J Med. 2005;118(9A):7S-11S
control

17
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 21
Guerci B, Drouin P, Grange V,
Bougneres P, Fontaine P,
Kerlan V, Passa P, Thivolet
Ch, Vialettes B, Charbonnel B;
ASIA Group
22
Hainsworth T
23 Murata GH, Shah JH, Hoffman
RM, Wendel CS, Adam KD,
Solvas PA, Bokhari SU,
Duckworth EC; Diabetes
Outcomes in Veterans Study
(DOVES)
24
Martin S, Schneider B,
Heinemann L, Lodwig V, Kurth
HJ, Kolb H, Scherbaum WA
25
Peterson KA
26
Shorr RI, Franse LV, Resnick
HE, Di Bari M, Johnson KC,
Pahor M
27
Turner RC, Cull CA, Frighi V,
Holman RR
HYPOGLYCEMIA 1 Brackenridge A, Wallbank H,
Lawrenson RA, Russell-Jones
D
2
Cox DJ, Gonder-Frederick LA,
Kovatchev BP, Young-Hyman
DL, Donner TW, Julian DM,
Clarke WL
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
Self-monitoring of blood glucose
signifcantly improves metabolic
control in patients with type 2
Diabetes Metab. 2003 Dec;29(6):587-94
diabetes mellitus: The Auto-
Surveillance Intervention Active
(ASIA) Study
How to maintain optimal glycemic
Nurs Times. 2005 Nov 29-Dec 5;101(48):19-20
control in diabetes
Intensified blood glucose monitoring
improves glycemic control in stable,
insulin-treated veterans with type 2 Diabetes Care. 2003 Jun;26(6):1759-63
diabetes: The Diabetes Outcomes in
Veterans Study (DOVES)
Self-monitoring of blood glucose in
type 2 diabetes and long-term Diabetologia. 2006 Feb;49(2):271-8. Epub 2005
outcome: An epidemiological cohort Dec 17
study
Diabetes care by primary care
physicians in Minnesota and J Fam Pract. 1994 Apr;38(4):361-7
Wisconsin
Glycemic control of older adults with
type 2 diabetes: findings from the
J Am Geriatr Soc. 2000 Mar;48(3):264-7
Third National Health and Nutrition
Examination Survey, 1988-1994
Glycemic control with diet,
sulfonylurea, metformin, or insulin in
patients with type 2 diabetes
mellitus: Progressive requirement for JAMA. 1999 Jun 2;281(21):2005-12
multiple therapies (UKPDS 49). UK
Prospective Diabetes Study
(UKPDS) Group
Emergency management of
Emerg Med J. 2006 Mar;23(3):183-5
diabetes and hypoglycemia
Biopsychobehavioral model of
severe hypoglycemia. II.
Diabetes Care. 1999 Dec;22(12):2018-25
Understanding the risk of severe
hypoglycemia
18
 3 Cox DJ, Kovatchev BP, Julian
DM, Gonder-Frederick LA,
Polonsky WH, Schlundt DG,
Clarke WL
4
Cox DJ, Kovatchev BP, Koev
D, Koeva L, Dachev S,
Tcharaktchiev D, Protopopova
A, Gonder Frederick L, Clarke
W with type 1 diabetes mellitus
Frequency of severe hypoglycemia
in insulin dependent diabetes
J Clin Endocrinol Metab. 1994 Dec;79(6):1659-62
mellitus can be predicted from self
monitoring blood glucose data
Hypoglycemia anticipation,
awareness and treatment training
(HAATT) reduces occurrence of Int J Behav Med. 2004;11(4):212-8
severe hypoglycemia among adults

5
Cryer PE, Davis SN, Shamoon
Hypoglycemia in Diabetes Diabetes Care. 2003 Jun;26(6):1902-12
H

6 Hypoglycemia in type 1 diabetes

Dagogo-Jack S mellitus: Pathophysiology and Treat Endocrinol. 2004;3(2):91-103
prevention
7

A comparison of glucagon and

Howell MA, Guly HR J Accid Emerg Med. 1997 Jan;14(1):30-2
glucose in prehospital hypoglycemia

Treatment of hypoglycemic coma

MacCuish AC, Munro JF, with glucagon, intravenous dextrose,
Lancet. 1970 Nov 7;2(7680):946-9
Duncan LJ and mannitol infusion in a hundred
diabetics

9 Pharmacokinetics and bioavailability

Muhlhauser I, Koch J, Berger
M
10
Patrick AW, Collier A, Hepburn
DA, Steedman DJ, Clarke BF,
Robertson C
11
Vermeulen MJ, Klompas M,
Ray JG, Mazza C, Morrison LJ
of injected glucagon: Differences
between intramuscular, Diabetes Care. 1985 Jan-Feb;8(1):39-42
subcutaneous, and intravenous
administration
Comparison of intramuscular
glucagon and intravenous dextrose
in the treatment of hypoglycemic Arch Emerg Med. 1990 Jun;7(2):73-7
coma in an accident and emergency
department
Subcutaneous glucagon may be
better than oral glucose for
Diabetes Care. 2003 Augl26(8):2472-3
prehospital treatment of
symptomatic hypoglycemia

19
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 12
Vukmir RB, Paris PM, Yealy Glucagon: Prehospital therapy for
Ann Emerg. Med. 1991 Apr;20(4):375-9
DM hypoglycemia

IMMUNIZATIONS 1

Immunization and prevention of

American Diabetes
influenza and pneumococcal Diabetes Care. 2003 Jan;26 Suppl1:126-128
Association
disease in people with diabetes

2 Bridges CB, Fukuda K, Uyeki

TM, Cox NJ, Singleton JA; Prevention and control of influenza.
Centers for Disease Control Recommendations of the Advisory MMWR Recomm Rep. 2002 Apr 12;51(RR-3):1-
and Prevention, Advisory Committee on Immunization 31
Committee on Immunization Practices (ACIP)
Practices
3 Prevention and control of influenza.
Recommendations of the Advisory MMWR Morb Mortal Wkly Rep. 2003 Apr
CDC
Committee on Immunization 25;52(No. RR-8):1-36
Practices (ACIP)
4 Influenza and pneumococcal
vaccination coverage among
Centers for Disease Control persons aged > or = 65 years and MMWR Morb Mortal Wkly Rep. 2004 Nov
and Prevention (CDC) persons aged 18-64 years with 5;53(43):1007-12
diabetes or asthma--United States,
2003
5 Reduced hospitalizations and death
Heymann AD, Shapiro Y,
associated with influenza
Chodick G, Shalev V, Kokia E, Diabetes Care. 2004 Nov;27(11):2581-4
vaccination among patients with and
Kramer E, Shemer J
without diabetes
6

Use of influenza and pneumococcal

Smith S, Poland GA Diabetes Care. 2000 Jan;23(1):95-108
vaccines in people with diabetes

7
Smith SA, Poland GA;
Influenza and pneumococcal
American Diabetes Diabetes Care. 2004 Jan;27 Suppl 1:S111-3
immunization in diabetes
Association

LIPIDS 1 Carbohydrate and fiber

recommendations for individuals
Journal of American College of Nutrition 2004;
Anderson JW et al with diabetes: A quantitative
23(1): 5-17
assessment and meta-analysis of
the evidence

20
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 2 Managing abnormal blood lipids. A
Berra FB et al Circulation 2005 Nov; 112 (20): 3184-209
collaborative approach
3 Comparison of fluvastatin +
fenofibrate combination therapy and
fluvastatin monotherapy in the
treatment of combined
Derosa G et al Clinical Therapeutics 2004;26(10): 1599-1607
hyperlipidemia, type 2 diabetes
mellitus, and coronary heart
disease: A 12-month, randomized,
double-blind, controlled trial
4 Executive Summary of the Third
Expert Panel on Detection, Report of the National Cholesterol
Evaluation, and Treatment of Education Program (NCEP) Expert
JAMA. 2001;285(19):2486-2497
High Blood Cholesterol in Panel on Detection, Evaluation, and
Adults Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III)
5
MRC/BHF Heart Protection Study of
Heart Protection Study cholesterol lowering with simvastatin
Lancet. 2002 Jul 6;360:7-22
Collaborative Group in 20,536 high-risk individuals: A
randomised placebo-controlled trial

6 MRC/BHF Heart Protection Study of

Heart Protection Study cholesterol lowering with simvastatin
Lancet. 2003 Jun 14;361:2005-2016
Collaborative Group in 5,963 people with diabetes: A
randomised placebo-controlled trial
7
Implications of recent clinical trials
for the National Cholesterol
Grundy S, et al Circulation. 2004 Jul 13;110:227-239
education Program Adult Treatment
Panel II guidelines

8
Management of dyslipidemia in
Haffner S Diabetes Care. 1998;21(1):160-178
adults with diabetes

9 Dietary treatment of
Henkin Y, Shai I, Zuk R,
hypercholesterolemia: Do dieticians
Brickner D, Zuilli I, Neumann Am J Med. 2000;109:549-555
do it better? A randomized
L, Shany S
controlled trial
10 Effect of combination therapy with
lipid-reducing drugs in patients with
Pasternak RC et al Annals of Internal Medicine
coronary heart disease and normal
cholesterol levels

21
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 11 Effects of ezetimibe added to on-
going statin therapy on the lipid
Simons L et al profile of hypercholesterolemic Current Medical Research and Opinion
patients with diabetes mellitus or
metabolic syndrome
12
Recent National Cholesterol
Stone N, Bilek S, Rosenbaum Education Program Adult Treatment The American Journal of Cardiology 2005; 96
S Panel III Update: Adjustments and Aug: 53-59
Options

13
Strandberg T, Vanhanen H Drug treatment for hyperlipidaemias EBM guidelines Oct 5 2003

14

Fields of dreams, fields of tears: a

Wierzbicki AS Int J Clin Pract 2006 Apr;60(4):442-49
perspective on the fibrate trials

15

Canadian Diabetes
Association Clinical Practice
Guidelines Expert Committee
Canadian Journal of Diabetes 2006;30(3):230-
Dyslipidemia in adults with diabetes
240

MEN’S HEALTH 1

Erectile dysfunction in diabetic

Chaiban JT, Azar ST J Med Liban 2004;52(4):217-9
patients

Pathophysiology of erectile
Saenz de Tejada I et al J Sex Med 2005(1):26:39
dysfunction

Diagnosing erectile dysfunction:

Foresta C et al Int J Androl 2005 Suppl 2:64:8
Flow-chart

22
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 4

Brown JS et al Urologic complications of diabetes Diabetes Care. 2005: 28(1): 177-85

MENTAL HEALTH 1

Detecting Alcoholism: The

Ewing JA., JAMA 1984; 252 (14): 1905-1907
CAGE Questionnaire

2
The Patient Health Questionnaire -2:
Kroenke K, Spitzer RL,
Validity of a Two Item Depression Med Care 2003; 41:1284-1292
Williams JB.
Screener.

Spitzer R, Kroenke K, Williams Validation and utility of a self-report Journal of the American Medical Association
J version of PRIME-MD: the PHQ 1999; 282: 1737-1744

4
Welch GW, Jacobson A, The Problem Areas in Diabetes
Polonsky W. (PAID) scale. An examination of its Diabetes Care 1997; 20(5): 760-766
clinical utility

RENAL DISEASE AND 1

MICRO-MACRO
ALBUMINURIA American Diabetes
Nephropathy in diabetes Diabetes Care. 2004 Jan; 27 (1): 79-83
Association

2 Preserving renal function in adults

Bakris GL, Williams M,
Dworkin L, Elliot WJ, Epstein
M, Toto R, Tuttle K, Douglas J,
Hsueh W, Sowers J
3 Brenner BM, Cooper ME, de
Zeeuw D, Keane WF, Mitch
WE, Parving HH, Remuzzi G,
Snapinn SM, Zhang Z,
Shahinfar S; RENAAL Study
Investigators
with hypertension and diabetes: a
consensus approach. National
Am J Kidney Dis. 2000 Sep;36(3):646-61
Kidney Foundation Hypertension
and Diabetes Executive Committees
Working Group
Effects of losartan on renal and
cardiovascular outcomes in patients
N Engl J Med. 2001 Sep 20;345(12):861-9
with type 2 diabetes and
nephropathy

23
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 4 Effect of intensive therapy on the
development and progression of
diabetic nephropathy in the Diabetes
DCCT Kidney Int. 1995 Jun;47(6):1703-20
Control and Complications Trial. The
Diabetes Control and Complications
(DCCT) Research Group
5 Proteinuria and other markers of
Eknoyan G, Hostetter T, chronic kidney disease: A position
Bakris GL, Hebert L, Levery statement of the national kidney
Am J Kidney Dis. 2003 Oct;42(4):617-22
AS, Parving HH, Steffes MW, foundation (NKF) and the national
Toto R institute of diabetes and digestive
and kidney diseases (NIDDK)
6 Risk factors for development of
incipient and overt diabetic
Gall MA, Hougaard P, Borch-
nephropathy in patients with non- BMJ. 1997 Mar 15;314(7083):783-8
Johnsen K, Parving HH
insulin dependent diabetes mellitus:
prospective, observational study
7
Microalbuminuria: Marker of
Garg JP, Bakris GL vascular dysfunction, risk factor for Vasc Med. 2002 Feb;7(1):35-43
cardiovascular disease

8
Effect of dietary protein restriction on
Hansen HP, Tauber-Lassen E,
prognosis in patients with diabetic Kidney Int. 2002 Jul;62(1):220-8
Jensen BR, Parving HH
nephropathy

9 Effects of ramipril on cardiovascular

and microvascular outcomes in
people with diabetes mellitus:
Heart Outcomes Prevention
Results of the HOPE study and Lancet. 2000 Jan 22;355(9200):253-9
Evaluation Study Investigators
MICRO-HOPE substudy. Heart
Outcomes Prevention Evaluation
Study Investigators
10 A meta-analysis of the effects of
Kasiske BL, Lakatua JD, Ma
dietary protein restriction on the rate Am J Kidney Dis. 1998 Jun;31(6):954-61
JZ, Louis TA
of decline in renal function
11 Very low levels of microalbuminuria
Klausen K, Borch-Johnsen K,
are associated with increased risk of
Feldt-Rasmussen B, Jensen Circulation. 2004 Jul 6;110(1):32-5. Epub 2004
coronary heart disease and death
G, Clausen P, Scharling H, Jun 21
independently of renal function,
Appleyard M, Jensen JS
hypertension, and diabetes
12 Screening for kidney disease in
Kramer H, Molitch ME Diabetes Care. 2005 Jul;28(7):1813-6
adults with diabetes
13 Renal insufficency in the absence of
Kramer HJ, Nguyen QD,
albuminuria and retinopathy among JAMA. 2003 Jun 25;289(24):3273-7
Curhan G, Hsu CY
adults with type 2 diabetes mellitus

24
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 14
Laffel LM, McGill JB, Gans DJ
15
Levey AS, Bosch JP, Lewis
JB, Greene T, Rogers N, Roth
D equation. Modification of Diet in
The beneficial effect of angiotensin-
converting enzyme inhibition with
captopril on diabetic nephropathy in
Am J Med. 1995 Nov;99(5):497-504
normotensive IDDM patients with
microalbumiuria. North American
Microalbuminuria Study Group
A more accurate method to estimate
glomerular filtration rate from serum
creatinine: A new prediction Ann Intern Med. 1999 Mar 16;130(6):461-70
Renal Disease Study Group

16

Specialist evaluation in chronic

Levinsky NG Ann Intern Med. 2002 Sep 17;137(6):542-3
kidney disease: Too little, too late

17
The effect of angiotensin-converting
Lewis EJ, Hunsicker LG, Bain enzyme inhibition on diabetic
N Engl J Med. 1993 Nov 11;329(20):1456-62
RP, Rohde RD nephropathy. The Collaborative
Study Group

18
Lewis EJ, Hunsicker LG,
Renoprotective effect of the
Clarke WR, Berl T, Pohl MA,
angiotensin-receptor antagonist
Lewis JB, Ritz E, Atkins RC, N Engl J Med. 2001 Sep 20;345(12):851-60
irbesartan in patients with
Rohde R, Raz I; Collaborative
nephropathy due to type 2 diabetes
Study Group

19 K/DOQI clinical practice guidelines

for chronic kidney disease:
National Kidney Foundation Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
Evaluation, classification, and
stratification
20 The effect of protein restriction on
Pijls LT, de Vries H, Donker
albuminuria in patients with type 2 Nephrol Dial Transplant. 1999 Jun;14(6):1445-53
AJ, van Eijk JT
diabetes mellitus: A randomized trial

25
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 21
Long-term renoprotective effect of
angiotensin-converting enzyme
Ravid M, Lang R, Rachmani
inhibition in non-insulin-dependent Arch Intern Med. 1996 Feb 12;156(3):286-9
R, Lishner M
diabetes mellitus. A 7-year follow up
study

22 Microalbuminuria is positively
associated with usual dietary
saturated fat intake and negatively
Riley MD, Dwyer T Am J Clin Nutr. 1998;67:50-57
associated with usual dietary protein
intake in people with insulin-
dependent diabetes mellitus
23
Effects of blood pressure control on
progressive renal disease in blacks
Hebert LA, et al Hypertension. 1997; 30(3pt1):428-35
and whites. Modification of Diet in
Renal Disease Study Group

SMOKING 1 Haire-Joshu D, Glasgow RE,

Smoking and diabetes Diabetes Care. 1999 22(11): 1887-98
Tibbs TL
WOMEN’S HEALTH 1

American Diabetes Preconception care of women with

Diabetes Care. 2004 Jan;27 Suppl 1:S76-8
Association diabetes

Chau DL, Edelman SV,

Osteoporosis and diabetes Curr Diab Rep. 2003 Feb;3(1):37-42
Chandran M

3 Preconception care of women with

Holing EV J Matern Fetal Med. 2000 Jan-Feb;9(1):10-3
diabetes: The unrevealed obstacles
4
Ivers RQ, Cumming RG,
Diabetes and risk of fracture: The
Mitchell P, Peduto AJ; Blue Diabetes Care. 2001 Jul;24(7):1198-203
Blue Mountains Eye Study
Mountains Eye Study

26
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.
 5 Schwartz AV, Hillier TA,
Sellmeyer DE, Resnick HE,
Older women with diabetes have a
Gregg E, Ensrud KE,
higher risk of falls: A prospective Diabetes Care. 2002 Oct;25(10):1749-54
Schreiner PJ, Margolis KL,
study.
Cauley JA, Nevitt MC, Black
DM, Cummings SR
6
Women, type 2 diabetes, and
Schwartz AV, Sellmeyer DE Curr Diab Rep. 2004 Oct;4(5):364-9
fracture risk

7 Schwartz AV, Sellmeyer DE,

Strotmeyer ES, Tylavsky FA,
Feingold KR, Resnick HE,
Diabetes and bone loss at the hip in J Bone Miner Res. 2005 Apr;20(4):596-603. Epub
Shorr RI, Nevitt MC, Black
older black and white adults 2004 Dec 13
DM, Cauley JA, Cummings
SR, Harris TB; Health ABC
Study
8

Tuominen JT, Impivaara O, Bone mineral density in patients with

Diabetes Care. 1999 Jul;22(7):1196-200
Puukka P, Ronnemaa T type 1 and type 2 diabetes

Consensus statement on diabetes Med J Aust. 2005 Feb 7;182(3):141; author reply
Walters BN, Senaratne S
control in preparation for pregnancy 141-2

27
Copyright © 2006 by Joslin Diabetes Center. All rights reserved. Any reproduction of this document which omits Joslin’s name or copyright notice is prohibited. This document may be reproduced for
personal use only. It may not be distributed or sold. It may not be published in any other format without the prior, written permission of Joslin Diabetes Center, Publications Department, 617-226-5815.